PPARγ Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages

BACKGROUND: Clinical trials have shown that treatment of patients with type 2 diabetes with pioglitazone, a peroxisome proliferator-activated receptor (PPAR)γ agonist, reduces cardiovascular events. However, the effect of PPARγ agonists on endoplasmic reticulum (ER) stress that plays an important ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Jiro, Ichiki, Toshihiro, Takahara, Yusuke, Kojima, Hiroshi, Sankoda, Chikahiro, Kitamoto, Shiro, Tokunou, Tomotake, Sunagawa, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464548/
https://www.ncbi.nlm.nih.gov/pubmed/26061913
http://dx.doi.org/10.1371/journal.pone.0128546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464548/
https://www.ncbi.nlm.nih.gov/pubmed/26061913
http://dx.doi.org/10.1371/journal.pone.0128546

Ejemplares similares